Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.

Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Keene CD, Kamboh MI, Kofler JK, Duque L, Gilbert JR, Gwirtsman HE, Buxbaum JD, Dickson DW, Frosch MP, Ghetti BF, Lunetta KL, Wang LS, Hyman BT, Kukull WA, Foroud T, Haines JL, Mayeux RP, Pericak-Vance MA, Schneider JA, Trojanowski JQ, Farrer LA, Schellenberg GD, Beecham GW, Montine TJ, Jun GR; Alzheimer’s Disease Genetics Consortium.

Nat Commun. 2020 Feb 3;11(1):667. doi: 10.1038/s41467-019-14279-8.

2.

The relationship between domain-specific subjective cognitive decline and Alzheimer's pathology in normal elderly adults.

Shokouhi S, Conley AC, Baker SL, Albert K, Kang H, Gwirtsman HE, Newhouse PA; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2019 Sep;81:22-29. doi: 10.1016/j.neurobiolaging.2019.05.011. Epub 2019 May 23.

PMID:
31207466
3.

Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.

Shokouhi S, Campbell D, Brill AB, Gwirtsman HE; Alzheimer's Disease Neuroimaging Initiative.

Brain Pathol. 2016 Sep;26(5):664-71. doi: 10.1111/bpa.12399.

4.

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment.

Shokouhi S, Mckay JW, Baker SL, Kang H, Brill AB, Gwirtsman HE, Riddle WR, Claassen DO, Rogers BP; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2016 Jan 15;8:2. doi: 10.1186/s13195-016-0172-3.

5.

Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.

Naj AC, Beecham GW, Martin ER, Gallins PJ, Powell EH, Konidari I, Whitehead PL, Cai G, Haroutunian V, Scott WK, Vance JM, Slifer MA, Gwirtsman HE, Gilbert JR, Haines JL, Buxbaum JD, Pericak-Vance MA.

PLoS Genet. 2010 Sep 23;6(9):e1001130. doi: 10.1371/journal.pgen.1001130.

6.

Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.

Salomon RM, Kennedy JS, Johnson BW, Urbano Blackford J, Schmidt DE, Kwentus J, Gwirtsman HE, Gouda JF, Shiavi RG.

Neuropsychopharmacology. 2005 Nov;30(11):2082-91.

7.

Association of a critical CSF tryptophan threshold level with depressive relapse.

Salomon RM, Kennedy JS, Johnson BW, Schmidt DE, Kwentus J, Gwirtsman HE, Ebert MH.

Neuropsychopharmacology. 2003 May;28(5):956-60. Epub 2003 Mar 19.

8.

Serial cerebrospinal fluid tryptophan and 5-hydroxy indoleacetic acid concentrations in healthy human subjects.

Kennedy JS, Gwirtsman HE, Schmidt DE, Johnson BW, Fielstein E, Salomon RM, Shiavi RG, Ebert MH, Parris WC, Loosen PT.

Life Sci. 2002 Aug 23;71(14):1703-15.

PMID:
12137916
9.

Standardized assessment of dysthymia: report of a National Institute of Mental Health conference.

Gwirtsman HE, Blehar MC, McCullough JP Jr, Kocsis JH, Prien RF.

Psychopharmacol Bull. 1997;33(1):3-11. Review. No abstract available.

PMID:
9133745
10.

Disruption of circadian MHPG rhythmicity in major depression.

Piletz JE, DeMet E, Gwirtsman HE, Halaris A.

Biol Psychiatry. 1994 Jun 1;35(11):830-42.

PMID:
8054405
11.

Binge eating disorder affects outcome of comprehensive very-low-calorie diet treatment.

Yanovski SZ, Gormally JF, Leser MS, Gwirtsman HE, Yanovski JA.

Obes Res. 1994 May;2(3):205-12.

12.
13.

The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate.

Gwirtsman HE, Szuba MP, Toren L, Feist M.

Psychopharmacol Bull. 1994;30(2):157-64.

PMID:
7831449
14.

Thyroid function in bulimia nervosa.

Spalter AR, Gwirtsman HE, Demitrack MA, Gold PW.

Biol Psychiatry. 1993 Mar 15;33(6):408-14.

15.

Case report of anorexia nervosa associated with Wilson's disease.

Gwirtsman HE, Prager J, Henkin R.

Int J Eat Disord. 1993 Mar;13(2):241-4.

PMID:
8477294
16.

Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss.

Yanovski SZ, Yanovski JA, Gwirtsman HE, Bernat A, Gold PW, Chrousos GP.

J Clin Endocrinol Metab. 1993 Mar;76(3):675-9.

PMID:
8445025
17.

Overview of the definition, prevalence, and comorbidity of bulimic disorders.

Gwirtsman HE.

Psychopharmacol Bull. 1993;29(1):109-14. Review. No abstract available.

PMID:
8378503
19.

Pituitary-adrenal-immune system in normal subjects and in patients with anorexia nervosa: the number of circulating helper T lymphocytes (CD4) expressing the homing receptor Leu8 is regulated in part by pituitary-adrenal products.

Chiappelli F, Gwirtsman HE, Lowy M, Gormley G, Nguyen LD, Nguyen L, Popow J, Esmail I, Fahey JL, Strober M.

Psychoneuroendocrinology. 1991;16(5):423-32.

PMID:
1725219
20.

Possible adverse drug interactions between fluoxetine and other psychotropics.

Lock JD, Gwirtsman HE, Targ EF.

J Clin Psychopharmacol. 1990 Oct;10(5):383-4. No abstract available.

PMID:
2258459
21.

Fluoxetine treatment of anorexia nervosa: an open clinical trial.

Gwirtsman HE, Guze BH, Yager J, Gainsley B.

J Clin Psychiatry. 1990 Sep;51(9):378-82.

PMID:
2102671
22.

Macroamylasemia.

Yanovski SZ, Gwirtsman HE.

J Am Board Fam Pract. 1990 Apr-Jun;3(2):140. No abstract available.

PMID:
1692178
23.

Disturbances of noradrenergic systems in normal weight bulimia: relationship to diet and menses.

Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR.

Biol Psychiatry. 1990 Jan 1;27(1):4-21.

PMID:
2297551
24.

Isoproterenol infusion test in anorexia nervosa: assessment of pre- and post-beta-noradrenergic receptor activity.

Kaye WH, George DT, Gwirtsman HE, Jimerson DC, Goldstein DS, Ebert MH, Lake CR.

Psychopharmacol Bull. 1990;26(3):355-9.

PMID:
2274636
25.

Amphetamine, but not methylphenidate, predicts antidepressant response.

Gwirtsman HE, Guze BH.

J Clin Psychopharmacol. 1989 Dec;9(6):453-4. No abstract available.

PMID:
2592595
26.

Apparent phase advance in diurnal MHPG rhythm in depression.

Gwirtsman HE, Halaris AE, Wolf AW, DeMet E, Piletz JE, Marler M.

Am J Psychiatry. 1989 Nov;146(11):1427-33.

PMID:
2817113
27.

Hyperamylasemia and its relationship to binge-purge episodes: development of a clinically relevant laboratory test.

Gwirtsman HE, Kaye WH, George DT, Carosella NW, Greene RC, Jimerson DC.

J Clin Psychiatry. 1989 Jun;50(6):196-204.

PMID:
2470728
28.

The effect of bingeing and vomiting on hormonal secretion.

Kaye WH, Gwirtsman HE, George DT.

Biol Psychiatry. 1989 Mar 15;25(6):768-80.

PMID:
2647157
29.

Decreased caloric intake in normal-weight patients with bulimia: comparison with female volunteers.

Gwirtsman HE, Kaye WH, Obarzanek E, George DT, Jimerson DC, Ebert MH.

Am J Clin Nutr. 1989 Jan;49(1):86-92.

PMID:
2912015
30.

Energy intake and dietary macronutrient content in women with anorexia nervosa and volunteers.

Gwirtsman HE, Kaye WH, Curtis SR, Lyter LM.

J Am Diet Assoc. 1989 Jan;89(1):54-7.

PMID:
2909592
31.

Central and peripheral ACTH and cortisol levels in anorexia nervosa and bulimia.

Gwirtsman HE, Kaye WH, George DT, Jimerson DC, Ebert MH, Gold PW.

Arch Gen Psychiatry. 1989 Jan;46(1):61-9.

PMID:
2535925
32.

Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.

Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.

Psychopharmacol Bull. 1989;25(3):433-8. Review.

PMID:
2533990
33.

Pattern of onset of bulimic symptoms in anorexia nervosa.

Kassett JA, Gwirtsman HE, Kaye WH, Brandt HA, Jimerson DC.

Am J Psychiatry. 1988 Oct;145(10):1287-8.

PMID:
3421352
34.

Relative importance of calorie intake needed to gain weight and level of physical activity in anorexia nervosa.

Kaye WH, Gwirtsman HE, Obarzanek E, George DT.

Am J Clin Nutr. 1988 Jun;47(6):989-94.

PMID:
3376913
35.

CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.

Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.

Psychoneuroendocrinology. 1988;13(3):265-72.

PMID:
2900533
36.

Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa.

Kaye WH, Gwirtsman HE, Brewerton TD, George DT, Wurtman RJ.

Psychiatry Res. 1988 Jan;23(1):31-43.

PMID:
2834764
37.

Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease.

Berrettini WH, Kaye WH, Sunderland T, May C, Gwirtsman HE, Mellow A, Albright A.

Neuropsychobiology. 1988;19(2):64-8.

PMID:
2465504
38.

CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain.

Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH.

Biol Psychiatry. 1988 Jan 1;23(1):102-5. No abstract available.

PMID:
2447961
39.

Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa.

Kaye WH, Berrettini WH, Gwirtsman HE, Chretien M, Gold PW, George DT, Jimerson DC, Ebert MH.

Life Sci. 1987 Nov 2;41(18):2147-55.

PMID:
2823041
40.

Seasonal dexamethasone suppression test results.

Brewerton TD, Gwirtsman HE.

Arch Gen Psychiatry. 1987 Oct;44(10):920-1. No abstract available.

PMID:
3662747
41.

Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.

Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW.

J Clin Endocrinol Metab. 1987 Feb;64(2):203-8.

PMID:
3491830
42.

Relationship of mood alterations to bingeing behaviour in bulimia.

Kaye WH, Gwirtsman HE, George DT, Weiss SR, Jimerson DC.

Br J Psychiatry. 1986 Oct;149:479-85.

PMID:
3814933
43.

Caloric intake necessary for weight maintenance in anorexia nervosa: nonbulimics require greater caloric intake than bulimics.

Kaye WH, Gwirtsman HE, Obarzanek E, George T, Jimerson DC, Ebert MH.

Am J Clin Nutr. 1986 Oct;44(4):435-43.

PMID:
3766430
44.
45.

Diurnal rhythm of 3-methoxy-4-hydroxyphenylglycol (MHPG): relationship between plasma and urinary levels.

DeMet EM, Halaris AE, Gwirtsman HE, Reno RM.

Life Sci. 1985 Nov 4;37(18):1731-41.

PMID:
4058250
46.

Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery.

Winterer J, Gwirtsman HE, George DT, Kaye WH, Loriaux DL, Cutler GB Jr.

J Clin Endocrinol Metab. 1985 Oct;61(4):693-7.

PMID:
2993344
47.

Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.

Gwirtsman HE, Roy-Byrne P, Gitlin MJ, Halaris A, Ahles S.

J Affect Disord. 1985 Sep;9(2):193-6.

PMID:
2932495
48.

The TRH stimulation test and reverse T3 in depression.

Sternbach HA, Gwirtsman HE, Gerner RH, Hershman J, Pekary E.

J Affect Disord. 1985 May-Jun;8(3):267-70.

PMID:
3160737
49.

Disturbances of norepinephrine metabolism and alpha-2 adrenergic receptor activity in anorexia nervosa: relationship to nutritional state.

Kaye WH, Gwirtsman HE, Lake CR, Siever LJ, Jimerson DC, Ebert MH, Murphy DL.

Psychopharmacol Bull. 1985;21(3):419-23. No abstract available.

PMID:
2994154
50.

Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa.

Kaye WH, Ebert MH, Gwirtsman HE, Weiss SR.

Am J Psychiatry. 1984 Dec;141(12):1598-601.

PMID:
6209991

Supplemental Content

Loading ...
Support Center